Table 2.
Assessment Criteria | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Study | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Total Score | Quality Assessment |
Almeida 2020 [23] | Y | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 7 | Good |
Arazi 2019 [22] | Y | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 9 | Excellent |
Arciero 2001 [24] | Y | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 7 | Good |
Bemben 2001[25] | Y | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 7 | Good |
Cribb 2007 [26] | Y | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 6 | Good |
Ferguson 2005 [27] | Y | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 6 | Good |
Hoffman 2006 [28] | Y | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 8 | Good |
Kaviani 2019 [29] | Y | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 7 | Good |
Kelly 1998 [30] | Y | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 7 | Good |
Larson 2000 [31] | Y | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 6 | Good |
Mills 2020 [32] | Y | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 8 | Good |
Noonan 1998 [33] | Y | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 8 | Good |
Pearson 1999 [34] | Y | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 7 | Good |
Peeters 1999 [35] | N | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 6 | Good |
Sandro 2012 [36] | Y | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 6 | Good |
Saremi 2010 [37] | Y | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 6 | Good |
Stone 1999 [38] | Y | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 7 | Good |
Stout 1999 [39] | Y | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 6 | Good |
Syrotuik 2000 [40] | Y | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 6 | Good |
Taylor 2011 [41] | Y | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 9 | Excellent |
Volek 1999 [42] | Y | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 7 | Good |
Wang 2018 [43] | Y | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 8 | Good |
Wilder 2002 [44] | Y | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 7 | Good |
1, eligibility criteria; 2, random allocation; 3, concealed allocation; 4, baseline comparability; 5, blinded subjects; 6, blinded therapists; 7, blinded assessors; 8, adequate follow-up; 9, intention-to-treat analysis; 10, between-group comparisons; 11, point estimates and variability. The total score represents the score of the PEDro scale. Item 1 was not scored. Y, yes; N, no.